Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

27.98USD
16 Nov 2018
Change (% chg)

$1.05 (+3.90%)
Prev Close
$26.93
Open
$26.66
Day's High
$28.42
Day's Low
$26.66
Volume
184,706
Avg. Vol
--
52-wk High
$35.55
52-wk Low
$21.67

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.25 December 17 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 -- -- --
(2) OUTPERFORM 2 -- -- --
(3) HOLD 1 -- -- --
(4) UNDERPERFORM 0 -- -- --
(5) SELL 0 -- -- --
No Opinion 0 -- -- --
Mean Rating 2.00 -- -- --

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 4 -0.25 -0.21 -0.32 --
Quarter Ending Mar-19 3 -0.27 -0.25 -0.30 --
Year Ending Dec-18 4 -2.74 -1.90 -4.09 --
Year Ending Dec-19 4 -1.29 -1.09 -1.43 --

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.00 0.00 -- -- --
Quarter Ending Mar-19 0.00 0.00 -- -- --
Year Ending Dec-18 0.00 0.00 -- -- --
Year Ending Dec-19 0.00 0.00 -- -- --
Earnings (per share)
Quarter Ending Dec-18 -0.25 -0.25 -- -- --
Quarter Ending Mar-19 -0.27 -0.27 -- -- --
Year Ending Dec-18 -2.74 -2.74 -- -- --
Year Ending Dec-19 -1.29 -1.29 -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 -- --
Quarter Ending Mar-19 0 0 -- --
Year Ending Dec-18 0 0 -- --
Year Ending Dec-19 0 0 -- --
Earnings
Quarter Ending Dec-18 0 0 -- --
Quarter Ending Mar-19 0 0 -- --
Year Ending Dec-18 0 0 -- --
Year Ending Dec-19 0 0 -- --